Investigations

Finkelstein Thompson investigates potential shareholder claims arising from the proposed acquisition of First Advantage Corp. by First American Corp.  

Finkelstein Thompson investigates potential shareholder claims arising from the proposed acquisition of FiberNet Telecom by Zayo Group. 

Finkelstein Thompson investigates claims that CVS Caremark violates medical confidentiality rights and penalizes patients who fill prescriptions with competitor pharmacies.  

Finkelstein Thompson LLP is currently investigating complaints that customers who bought antivirus software were later charged for “renewal subscriptions” without their knowledge or consent.

Finkelstein Thompson LLP is currently investigating potential shareholder claims in connection with Wind River Systems, Inc.’s (NASDAQ: WIND) proposed sale to Intel Corporation.

Finkelstein Thompson investigates potential shareholder claims arising from the proposed acquisition of CuraGen Corporation by Celldex Therapeutics

Finkelstein Thompson investigates potential shareholder claims arising from the proposed acquisition of Natco Group by Cameron International

Finkelstein Thompson investigates reports that Blue Rhino and Amerigas systematically reduced the amount of propane in refilled propane tanks

Finkelstein Thompson investigates potential shareholder claims arising out of the acquisition of Cougar Biotech by Johnson & Johnson

Finkelstein Thompson investigates potential shareholder claims arising from the proposed acquisition of IDM Pharma by Takeda. 

Finkelstein Thompson investigates potential shareholder claims arising from the proposed acquisition of VNUS Medical Technologies by Covidien. 

Finkelstein Thompson investigates potential claims against the board of directors of D&E Communications arising out of their acquisition by Windstream Corp. 

Finkelstein Thompson LLP investigates potential shareholder claims in connection with the proposed buyout of Foundation Coal by Alpha Natural Resources

Finkelstein Thompson investigates potential shareholder claims arising from the proposed acquisition of Catapult Communications by Ixia

Finkelstein Thompson is currently investigating possible shareholder claims related to the acquisition of Atlas Energy Resources LLC by Atlas America, Inc.

Finkelstein Thompson LLP investigates possible shareholder claims relating to the acquisition of PepsiAmericas, Inc. by PepsiCo, Inc. 

Finkelstein Thompson LLP investigates possible shareholder claims relating to the acquisition of Pepsi Bottling Group by PepsiCo, Inc. 

FT investigates reports that consumers may have been offered free private Medicare plans which after the rescission period has ended carry a monthly premium.

Finkelstein Thompson LLP is currently investigating possible shareholder claims relating to the acquisition of Metavante Technologies, Inc. by Fidelity National Information Services for $2.94 billion in stock.

Finkelstein Thompson LLP is currently investigating potential shareholder claims in connection with Cox Media's March 23, 2008 announcement of a cash tender offer for all outstanding shares of Cox Radio, Inc. common stock.

Finkelstein Thompson LLP is investigating potential claims arising out of the proposed acquisition of Hearst-Argyle Television, Inc. by Hearst Corporation .

Finkelstein Thompson investigates claims that Steel Dynamics made false and misleading statements regarding the Company's business and financial results. 

FT investigates claims that the Emageon Board of Directors may have breached their fiduciary duties in connection with AMICAS' proposed cash tender offer for all outstanding shares of Emageon.

Finkelstein Thompson LLP Investigates Hermetic Compressor Overcharges 

Finkelstein Thompson investigates potential shareholder claims involving Colonial BancGroup.  

Finkelstein Thompson LLP is investigating allegations that certain HP laptops experience unusually high rates of wireless connection failures.   

Finkelstein Thompson LLP is investigating allegations that certain models display unwanted multicolored vertical lines.

Finkelstein Thompson investigates reports that consumers may have purchased olive oil which, contrary to its label, contained oils other than olive oil

Finkelstein Thompson LLP is investigating allegations that large health insurers may have substantially underpaid "usual, customary and reasonable" (UCR) medical provider fees to insured consumers who arrange for out-of –network medical services. The underpayments can be costly to the insured consumer and to medical care providers.

Finkelstein Thompson files class action suit against Heartland Payment Systems.  

Finkelstein Thompson investigates allegations that the bass drum foot pedal for the video game Rock Band is defective.  

Finkelstein Thompson LLP is investigating allegations that Netflix, Inc. (“Netflix”) may have wrongfully charged too much for online DVD rentals.

FT Announces investigation of RBS Worldpay for a security and privacy breach of sensitive personall information belonging to pre-paid cardholders.

Finkelstein Thompson LLP Announces Investigation into American Land Lease, Inc. ("ANL") 

Finkelstein Thompson investigates allegations that UBS committed violations of securities laws in the underwriting, marketing, and/or selling of Lehman Principal Protection Notes 

Finkelstein Thompson investigates allegations that Farmer Mac misrepresented its financial and operational results  

Finkelstein Thompson Announces Investigation Into GSI Group, Inc. 

Finkelstein Thompson investigates mislabeling of Bayer Women's Low Dose Aspirin and Bayer Aspirin with Heart Advantage.  

Finkelstein Thompson investigates potential shareholder and derivative claims involving KV Pharmaceutical  following the announcement that its second quarter earnings filing would be indefinitely delayed due to a continuing investigation into recent financial and operational irregularities.  

Finkelstein Thompson investigates potential shareholder claims arising from the proposed acquisition of Alpharma by King Pharmaceuticals.  

Finkelstein Thompson investigates potential shareholder claims involving AtriCure.  

Finkelstein Thompson LLP investigates a data breach that occurred at Express Scripts.  

Finkelstein Thompson investigates allegations that some cable companies changed their broadcasting signals, rendering third party devices obsolete. 

Finkelstein Thompson investigates allegations that cable television providers improperly bundle premium cable services with the rental of a cable box.  

Finkelstein Thompson announces investigation of Cadence Design Systems. 

Finkelstein Thompson LLP Announces Investigation of Perini Corporation. 

Finkelstein Thompson LLP Investigates Electronic Arts Games Spore and Mass Effect. 

Finkelstein Thompson investigates allegations that major cell phone companies fixed text message prices.

Finkelstein Thompson investigates wrongful overcharges for fertilizer.

Finkelstein Thompson investigates allegations that major steel manufacturers conspired to overcharge customers.

Finkelstein Thompson investigates potential misrepresentations in credit card advertising.

Finkelstein Thompson LLP Investigates Novatel Wireless, Inc. for Potential Violations of Securities Laws.

Finkelstein Thompson investigates Bank of America's acquisition of Merrill Lynch.

Finkelstein Thompson LLP investigates NVIDIA graphics chip defect.

Finkelstein Thompson LLP investigates potential shareholder claims against NVIDIA. 

Finkelstein Thompson investigates potential Auction Rate Securities Claims Against H&R Block Financial Advisors Inc. and Northern Trust Corp.

Finkelstein Thompson investigates claims that printers prevent users from printing before toner has run out. 

Finkelstein Thompson LLP Investigates Possible UAL Securities Fraud

Finkelstein Thompson LLP Investigates China Shenghuo Pharmaceutical Holdings, Inc.

Finkelstein Thompson Investigates Early Termination Fees Charged by Service Providers. 

The law firm of Finkelstein Thompson LLP is currently investigating potential shareholder claims arising from the proposed merger of APP Pharmaceuticals, Inc. with Fresenius, SE.

Finkelstein Thompson LLP Investigates Harris Stratex Restatement

New Study Reveals Vytorin May Increase the Risk of Cancer

FT investigates dangerous side effects of Trasylol

FT investigates Electronic Arts, Inc. for alleged anticompetitive activity.

Investigation on behalf of purchasers of oil, air, and transmission filters.

Finkelstein Thompson LLP is investigating claims that several Herbalife products contain high levels of lead.

Investigation on behalf of shareholders of Citigroup Inc's Falcon and ASTA/MAT hedge funds.

FT investigates potential shareholder claims against Wendy's International, Inc.

Investigation of security breach at LendingTree LLC.

FT investigates allegations that sea shippers wrongfully overcharged their customers.

FT announces investigation of Genworth Financial for a security and privacy breach of their customers' credit information.

FT announces investigation of WellPoint, Inc. for a security and privacy breach of their customer's medical data and social security numbers.

Finkelstein Thompson LLP is investigating the failure of many national banks to properly disclose key account terms and fees.

FT announces investigation of Davidson Companies for a security and privacy breach of their client's sensitive personal information.

Finkelstein Thompson LLP investigates Bear Stearns 401(K) plans.

Investigation of Societe Generale SPO.

Finkelstein Thompson LLP investigates "frozen" auction rate securities.

FT investigates the marketing and sale of Toshiba HD DVD players.

Finkelstein Thompson LLP investigates possible overcharges to patients using out-of-network physicians.

Finkelstein Thompson LLP announces investigation of Bank of America Corporation 401(K) Plans. 

Investigation of title insurance companies who overcharge homeowners.

Investigation of cholesterol drug Vytorin.

FT announces investigation of CellCyte Genetics Corp.

Investigation of "shortfall charges".

Investigation of claims that some companies may be overcharging for management of their 401(k) plans.